|
Furosoral vet
|
10 mg
|
V/MRP/14/0062
|
Le Vet Beheer B.V., Nīderlande
|
QC03CA01
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Furosemide
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande;Artesan Pharma, Vācija;GENERA Inc., Horvātija
|
| Date of authorisation/renewal: |
01-Aug-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[DOCX] 20032024LI (20-Mar-2024)
|
| Labelling text: |
[DOCX] 20032024M (20-Mar-2024)
|
| Summary of product characteristics: |
[DOCX] 20032024ZA (20-Mar-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/14/0062-01 |
10 mg |
1 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0062-02 |
10 mg |
2 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0062-03 |
10 mg |
3 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0062-04 |
10 mg |
4 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0062-05 |
10 mg |
5 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0062-06 |
10 mg |
6 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0062-07 |
10 mg |
7 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0062-08 |
10 mg |
8 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0062-09 |
10 mg |
9 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0062-10 |
10 mg |
10 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0062-11 |
10 mg |
25 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0062-12 |
10 mg |
50 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0062-13 |
10 mg |
100 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0062-14 |
10 mg |
1 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/MRP/14/0062-15 |
10 mg |
2 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/MRP/14/0062-16 |
10 mg |
3 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/MRP/14/0062-17 |
10 mg |
4 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/MRP/14/0062-18 |
10 mg |
5 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/MRP/14/0062-19 |
10 mg |
6 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/MRP/14/0062-20 |
10 mg |
7 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
|
|
Furosoral vet
|
40 mg
|
V/MRP/14/0063
|
Le Vet Beheer B.V., Nīderlande
|
QC03CA01
|
dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Furosemide
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande;Artesan Pharma, Vācija;GENERA Inc., Horvātija
|
| Date of authorisation/renewal: |
01-Aug-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
MRP
|
| Package leaflet: |
[DOCX] 20032024LI (20-Mar-2024)
|
| Labelling text: |
[DOCX] 20032024M (20-Mar-2024)
|
| Summary of product characteristics: |
[DOCX] 20032024ZA (20-Mar-2024)
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/MRP/14/0063-01 |
40 mg |
1 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0063-02 |
40 mg |
2 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0063-03 |
40 mg |
3 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0063-04 |
40 mg |
4 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0063-05 |
40 mg |
5 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0063-06 |
40 mg |
6 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0063-07 |
40 mg |
7 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0063-08 |
40 mg |
8 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0063-09 |
40 mg |
9 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0063-10 |
40 mg |
10 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0063-11 |
40 mg |
25 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0063-12 |
40 mg |
50 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0063-13 |
40 mg |
100 |
PVH/PVDH alumīnija blisteris (caurspīdīgs), 10 tablete |
-
|
| V/MRP/14/0063-14 |
40 mg |
1 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/MRP/14/0063-15 |
40 mg |
2 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/MRP/14/0063-16 |
40 mg |
3 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/MRP/14/0063-17 |
40 mg |
4 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/MRP/14/0063-18 |
40 mg |
5 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/MRP/14/0063-19 |
40 mg |
6 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
| V/MRP/14/0063-20 |
40 mg |
7 |
PVDH/PE/PVH/Al blisteris, 10 tablete |
-
|
|
|
Furosoral
|
10 mg
|
V/I/21/0025
|
Le Vet Beheer B.V., Nīderlande
|
QC03CA01
|
dogs; cats
|
|
Medicinal product information
| Pharmaceutical form: |
tablets
|
| International name (active substance): |
Furosemide
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Lelypharma B.V., Nīderlande;Artesan Pharma, Vācija;GENERA Inc., Horvātija
|
| Date of authorisation/renewal: |
30-Mar-2021
|
| Marketing authorisation valid until: |
29-Mar-2026
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOC] 05112024LI (05-Nov-2024)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/21/0025-05 |
10 mg |
5 |
PVH/PVDH alumīnija blisteris, 10 tablete |
[PDF]
[PDF]
|
|